All sites C00-96,D32-33,D42-43,D45-47,D76 154 88.9 3.5 5.6 0.6 1.4
Mouth, pharynx C00-14 3 100.0 - - - -
  Lip C00 0 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 - - - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 30 90.1 4.6 3.3 0.7 1.3
  Oesophagus C15 3 100.0 - - - -
  Stomach C16 3 100.0 - - - -
  Small intestine C17 1 66.7 33.3 - - -
  Colon C18 7 94.4 - 5.6 - -
  Rectum, rectosigmoid C19-20 6 96.7 - - 3.3 -
  Anus C21 1 100.0 - - - -
  Liver C22 3 100.0 - - - -
  Gallbladder, bile ducts C23-24 2 40.0 40.0 20.0 - -
  Pancreas C25 5 79.2 8.3 4.2 - 8.3
  Other digestive organs C26 1 100.0 - - - -
Respiratory organs C30-39 22 50.5 15.6 29.4 0.9 3.7
  Nose, sinuses C30-31 - - - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 21 49.5 16.5 31.1 1.0 1.9
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 5 100.0 - - - -
Skin, non-melanoma C44 8 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 1 85.7 - - - 14.3
Breast C50 0 100.0 - - - -
Male genital organs C60-63 47 98.7 - - 0.4 0.9
  Prostate C61 45 98.7 - - 0.4 0.9
  Testis C62 1 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 16 100.0 - - - -
  Kidney C64 5 100.0 - - - -
  Bladder and urinary tract2 C65-68 10 100.0 - - - -
Eye C69 - - - - - -
Brain, central nervous system C70-72,D32-33,D42-43 4 88.9 - 11.1 - -
Thyroid gland C73 1 75.0 25.0 - - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 2 77.8 - 22.2 - -
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 14 88.7 2.8 2.8 2.8 2.8
  Hodgkin lymphoma C81 0 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 7 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 2 55.6 - 22.2 - 22.2
  Leukaemia C91-95 4 80.0 10.0 - 10.0 -
  Myelodysplastic syndromes D46 0 100.0 - - - -
  Myeloproliferaitive neoplasms D45,D47 0 100.0 - - - -
Not included above
  Basal cell carcinoma of the skin 52 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.